These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15038877)

  • 21. Antibiotic-resistant gonorrhoea in a London GUM clinic.
    Nwokolo NC; Boag FC
    Int J STD AIDS; 2002 Feb; 13(2):137-8. PubMed ID: 11839173
    [No Abstract]   [Full Text] [Related]  

  • 22. Gonorrhoea treatment failure and ciprofloxacin resistance.
    Ng PP; Chan RK; Ling AE
    Int J STD AIDS; 1998 Jun; 9(6):323-5. PubMed ID: 9671244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
    Unemo M; Golparian D; Hestner A
    Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First case of spectinomycin resistant Neisseria gonorrhoeae isolate in New Delhi, India.
    Bala M; Ray K; Salhan S
    Sex Transm Infect; 2005 Apr; 81(2):186-7. PubMed ID: 15800110
    [No Abstract]   [Full Text] [Related]  

  • 25. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011.
    Unemo M; Golparian D; Stary A; Eigentler A
    Euro Surveill; 2011 Oct; 16(43):. PubMed ID: 22085601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Increasing incidence of ciprofloxacin resistant gonorrhea in Sweden. Choose a correct antibiotic and follow up the treatment!].
    Berglund T; Colucci B; Lund B; Qvarnström I; Sandström E
    Lakartidningen; 2004 Jul; 101(28-29):2332-5. PubMed ID: 15291311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006.
    Su X; Jiang F; Qimuge ; Dai X; Sun H; Ye S
    Sex Transm Dis; 2007 Dec; 34(12):995-9. PubMed ID: 17595594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
    Harry TC
    Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
    [No Abstract]   [Full Text] [Related]  

  • 29. Ciprofloxacin resistance in gonococci.
    Ison C; Martin I; Ivens D; Philip S; Greene L
    Lancet; 2001 Mar; 357(9258):803. PubMed ID: 11253997
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].
    Koedijk FD; van den Broek I; Stirbu-Wagner I; van Bergen JE
    Ned Tijdschr Geneeskd; 2013; 157(24):A5642. PubMed ID: 23759175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing resistance to ciprofloxacin among isolates of Neisseria gonorrhoea in Dublin.
    Hopkins S; Coleman C; Kelleher M; Keating S; Clarke S; O'Connell B; Mulcahy F; Bergin C
    Ir Med J; 2005; 98(7):208-9. PubMed ID: 16185017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
    Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
    N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada.
    Sarwal S; Wong T; Sevigny C; Ng LK
    CMAJ; 2003 Apr; 168(7):872-3. PubMed ID: 12668548
    [No Abstract]   [Full Text] [Related]  

  • 34. Increase of Neisseria gonorrhoeae ciprofloxacin resistance in France in 2001-2003.
    Herida M; Desenclos JC; Martin IM; Goulet V; Laurent E; Sednaoui P
    Sex Transm Dis; 2006 Jan; 33(1):6-7. PubMed ID: 16385214
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
    Unemo M; Golparian D; Potočnik M; Jeverica S
    Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London.
    Martin IM; Ison CA; Aanensen DM; Fenton KA; Spratt BG
    J Infect Dis; 2005 Oct; 192(7):1191-5. PubMed ID: 16136461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study.
    Ota KV; Fisman DN; Tamari IE; Smieja M; Ng LK; Jones KE; Diprima A; Richardson SE
    Clin Infect Dis; 2009 May; 48(9):1237-43. PubMed ID: 19323630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.
    Trembizki E; Guy R; Donovan B; Kaldor JM; Lahra MM; Whiley DM;
    Lancet Infect Dis; 2016 Sep; 16(9):1005-1006. PubMed ID: 27684341
    [No Abstract]   [Full Text] [Related]  

  • 39. From the Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
    JAMA; 2002 Dec; 288(23):2961-3. PubMed ID: 12492093
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA gyrase gene in Neisseria gonorrhoeae as indicator for resistance to ciprofloxacin and species verification.
    Lindbäck E; Gharizadeh B; Ataker F; Airell A; Jalal S; Nyrén P; Wretlind B
    Int J STD AIDS; 2005 Feb; 16(2):142-7. PubMed ID: 15807943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.